And I'm excited to welcome Luke Sarsfield, Chairman and CEO of Ridgepost Capital, also formerly known as P10, just for a little hope there for folks. Ridgepost Capital is a multi-asset class private ...

Well, good morning, everyone, and welcome to Cullinan Therapeutics Immunology Day. Today is an important milestone for Cullinan and also the way autoimmune diseases may be treated in the future. As ...